Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease

Am J Cardiol. 2003 May 1;91(9):1116-9. doi: 10.1016/s0002-9149(03)00161-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Anticholesteremic Agents / therapeutic use
  • Aspirin / therapeutic use
  • Atorvastatin
  • Biphenyl Compounds / therapeutic use*
  • Cholesterol, LDL / blood
  • Coronary Disease / drug therapy*
  • Coronary Disease / immunology
  • Drug Therapy, Combination
  • Female
  • Heptanoic Acids / therapeutic use
  • Humans
  • Interleukin-6 / blood*
  • Irbesartan
  • Isoquinolines / therapeutic use*
  • Male
  • Middle Aged
  • Monocytes / metabolism*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pyrroles / therapeutic use
  • Quinapril
  • Tetrahydroisoquinolines*
  • Tetrazoles / therapeutic use*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anticholesteremic Agents
  • Biphenyl Compounds
  • Cholesterol, LDL
  • Heptanoic Acids
  • Interleukin-6
  • Isoquinolines
  • Platelet Aggregation Inhibitors
  • Pyrroles
  • Tetrahydroisoquinolines
  • Tetrazoles
  • Atorvastatin
  • Irbesartan
  • Aspirin
  • Quinapril